Abstract
Aims—A routine immunohistochemical (IHC) assay is now commonly used for determining the oestrogen receptor (ER) and progesterone receptor (PR) status of women with breast cancer. To date, no large studies...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have